Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Biosyn begins phase III pivotal trial of lead product for prevention of HIV transmission

May 24, 2004

Pfizer researchers present another series of HIV RT inhibitors

May 21, 2004

FDA grants priority review to fixed dose combination of Viread and Emtriva

May 20, 2004

Two series of HIV RT inhibitors in early development at Pfizer

May 19, 2004

BMS, Gilead and Merck to develop fixed-dose combination of three anti-HIV drugs

May 19, 2004

Phase I trial begins with HIV vaccine based on Avant's Therapore technology

May 18, 2004

Hemispherx Biopharma to launch African trial of Alferon LDO for HIV

May 13, 2004

HE-2000 reduces HIV load, opportunistic infections in AIDS patients

May 12, 2004

Completion of ReceptoPharm's HIV in vitro studies

May 10, 2004

Samaritan advances HIV pipeline

May 10, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...